| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/24/2007 | CA2630323A1 Random copolymer compositions for treating unwanted immune response |
| 05/24/2007 | CA2629715A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | CA2629545A1 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 05/24/2007 | CA2629532A1 Method of expanding double negative t cells |
| 05/24/2007 | CA2629314A1 Tec kinase inhibitors |
| 05/24/2007 | CA2628630A1 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | CA2626122A1 Compositions comprising lipoxygenase inhibitors and cyclodextrin |
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1787997A1 MU-1, member of the cytokine receptor family |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1786787A1 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE |
| 05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |
| 05/23/2007 | EP1786439A2 Methods of activating nkt cells |
| 05/23/2007 | EP1786433A2 Betulinol derivatives as anti-hiv agents |
| 05/23/2007 | EP1786410A2 The treatment of inflammatory disorders and pain |
| 05/23/2007 | EP1786384A1 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 05/23/2007 | EP1786265A2 Novel compositions and methods of treatment |
| 05/23/2007 | EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/23/2007 | EP1625127B1 Azaindole compounds as kinase inhibitors |
| 05/23/2007 | EP1530494B1 A pharmaceutical preparation containing palladium complex compounds |
| 05/23/2007 | EP1237845B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1968931A Pyridine analogs as C5A antagonists |
| 05/23/2007 | CN1968708A Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966068A Transfer factor solution containing cluster water used for animals |
| 05/23/2007 | CN1966062A Medicinal decoction for treating urticaria occurred in menstrual period and preparation process thereof |
| 05/23/2007 | CN1965985A Orally administered Chinese medicinal mixture for treating infant allergic rhinitis and preparation process thereof |
| 05/23/2007 | CN1965938A Drink capable of treating urticaria |
| 05/23/2007 | CN1965915A Method for extracting bitter buckwheat flavone in high purity |
| 05/23/2007 | CN1965894A Prunella vulgaris polysaccharide having immune activity, preparation method and application thereof |
| 05/23/2007 | CN1965893A Liquid formulation for treating allergic rhinitis |
| 05/23/2007 | CN1965892A Liquid formulation for treating allergic rhinitis |
| 05/23/2007 | CN1965822A Sustained release formulation of bilobalide-B and preparation process thereof |
| 05/23/2007 | CN1965813A Compound soft capsule of propolis |
| 05/23/2007 | CN1965810A Sustained release microsphere formulation of thymosin alpha-1, preparation process and use thereof |
| 05/23/2007 | CN1965695A Health food capable of enhancing immunity and preparation method thereof |
| 05/23/2007 | CN1317382C Amauoderma rude liquid fermenting method and product obtained thereby |
| 05/23/2007 | CN1317304C Fusion protein, gene encoding same, and expression method and use thereof |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 05/23/2007 | CN1317034C Nuclec acid adjuvants |
| 05/23/2007 | CN1316983C Echinacea angustifolia extracts |
| 05/23/2007 | CN1316980C Medicinal use of spanish moss of Chinese traditional medicine |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220827 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 05/22/2007 | US7220755 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220559 Development of human monoclonal antibodies and uses thereof |
| 05/22/2007 | US7220551 Vaccine containing human papillomarus virus antigen, aluminum hydroxide and a preferential stimulator of TH1 cell response such as 3 De-O-acylated monophosphoryl lipid A (3D-MPL) |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | CA2320040C Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/22/2007 | CA2208241C Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
| 05/22/2007 | CA2119236C Use of ifn-gamma for the treatment of infections in transplant recipients |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/18/2007 | WO2007056578A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 05/18/2007 | WO2007055926A1 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007054989A1 Method for the preparation of anallergic probiotic bacterial cultures and related use |
| 05/18/2007 | WO2007054587A1 Oral tolerance promotion with glycated proteins |
| 05/18/2007 | WO2007053952A1 Platelet factor-4 (pf-4) analogs and their use |
| 05/18/2007 | WO2007033140A3 Prok2 antagonists and methods of use |
| 05/18/2007 | WO2007031832A3 Use of bipyridine compound 'caerulomycin a' derivatives and analogs thereof as immunosuppressive agents |
| 05/18/2007 | WO2006110577A3 Use of fril proteins for reducing the production of pro-inflammatory cytokines |
| 05/18/2007 | CA2629485A1 Oral tolerance promotion with glycated proteins |
| 05/18/2007 | CA2628254A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 05/18/2007 | CA2628113A1 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 05/18/2007 | CA2624905A1 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/18/2007 | CA2624903A1 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/18/2007 | CA2624580A1 Method for the preparation of anallergic probiotic bacterial cultures and related use |
| 05/17/2007 | US20070112205 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112179 Novel compounds |
| 05/17/2007 | US20070112059 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112022 Piperidine derivatives as ccr5 receptor modulators |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 05/17/2007 | US20070110673 Allergen peptide fragments and use thereof |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |